A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress
Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
EXTEND is a dose escalation study of NanO2 in patients with mild respiratory distress who are at risk for mechanical ventilation. The study will establish dosing guidelines for a Phase 2 study.